Page 5 - Julien Valton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEW YORK, May 16, 2022 Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today will present its first. | May 16, 2022

New yorkUnited statesFrance generalNorth carolinaAshleyr robinsonMargaret gandolfoJulien valtonArthur strilPascalyne wilsonAllogene therapeutics incEvasive properties usingAmerican society of cellWaltere washington convention centerCellectis the company euronext growthEuronext growthAmerican society